OTC

Strength

5; 100; 2.5 mg/5mL; mg/5mL; mg/5mL

Manufacturer

RB Health (US) LLC

NDC

63824028267

Classification

Brand

Dosage Form

SOLUTION

Route

ORAL

Last Updated

5/7/2014

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

7/17/2012

Pharmacological Classes

Adrenergic alpha1-Agonists
Decreased Respiratory Secretion Viscosity
Expectorant
Increased Respiratory Secretions
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-1 Adrenergic Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

N/A